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ABSTRACT
The Bracket™ is a proprietary blend, pre-workout supplement whose primary active ingredients consists
mostly of a mixture of creatine, B-complex vitamins, and a glycerol/taurine combination. It has been
third party tested for ingredient accuracy, and is also certified by NSF, meaning that it is certified for
sports consumption. Previous research has been done on the ingredients within the supplement utilizing
male demographics. However, there is limited research done on the pre-workout supplement as a whole.
The little research done has showed no increases in any variables such as power output
(relative/absolute) and/or rate of fatigue. Very little research has been done utilizing a female
population, let alone athletic females. PURPOSE: To examine the effect of a commercially available preworkout supplement (The Bracket™), in athletic females, on absolute peak power (APP), absolute mean
power (AMP), relative peak power (RPP), relative mean power (RMP), rate of fatigue (FTR), absolute
total work (ATW), and relative total work (RTW) utilizing the Wingate Anaerobic Cycle Test (WACT), a
30-s supra maximal exercise protocol. METHODS: Thirteen athletic females, ages 18-30, with no prior
hamstrings or quadriceps injuries within the last years were recruited. All subjects underwent three
experimental trials [treatment (TRT, supplement with Gatorade®), placebo (PLC, Gatorade®), and a
control (CON, water)] in a single blind balanced crossover design. During the trials the subjects had to
ingest one of the three liquids in an 8 ounce serving thirty minutes prior to engaging in the WACT. Each
trial was performed approximately one week apart. The differences in the dependent variables between
treatments were analyzed using an ANOVA (0 between, 1 within), α=0.05. RESULTS: No significant
difference between trials were seen for APP (TRT=715 ± 126 W; PLC=71 6± 125 W; CON=696 ± 147 W)
(p=0.2940), AMP (TRT=446 ± 94 W; PLC=436 ± 85 W; CON=441 ± 91 W)(p=0.3930), RPP (TRT=11.6 ±. 1.4
W·kg-1; PLC=11.6 ±. 1.5 W·kg-1; CON=11.3 ±. 1.5 W·kg-1)(p=0.2280), RMP (TRT=7.3 ±. 1.4 W·kg-1; PLC=7.1
± 1.1 W·kg-1; CON=7.2 ±. 1.3 W·kg-1)(p=0.3920), FTR (TRT=62 ± 13%; PLC=61 ± 11%; CON=59 ± 11%)
(p=0.1920), ATW (TRT=13368 ± 2798 J; PLC=13066 ± 2550 J; CON=13246 ± 2749 J)(p=0.4100), or RTW
(TRT=218 ± 42 J·kg-1; PLC=212 ± 33 J·kg-1; CON= 215 ± 38 J·kg-1)(p=0.4080). CONCLUSION: Ingestion of
(The Bracket™) prior to exercise does not affect performance on the WACT in athletic females.
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